Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12617000469314
Ethics application status
Approved
Date submitted
14/03/2017
Date registered
31/03/2017
Date last updated
23/10/2020
Date data sharing statement initially provided
25/09/2019
Type of registration
Prospectively registered
Titles & IDs
Public title
Do measures of brain activity predict recovery of the ability to communicate after stroke and predict response to speech therapy?
Query!
Scientific title
An examination of whether measures of brain function and structure in subacute post-stroke aphasia predict language recovery (naming and comprehension) and word retrieval treatment response at 3 months and 6 months post stroke-onset.
Query!
Secondary ID [1]
291239
0
NHMRC - APP1104194
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
PAPAR
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Aphasia post stroke
302174
0
Query!
Condition category
Condition code
Stroke
301783
301783
0
0
Query!
Ischaemic
Query!
Stroke
302007
302007
0
0
Query!
Haemorrhagic
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
The patient cohort will be randomly assigned to either treatment or a usual care control condition (stratified based on severity of language deficit).
Prior to receiving treatment or usual care, all participants will undertake a neuroimaging scan, including a language-based functional MRI, which will be used as a predictor for language recovery.
Therapy group:
- The therapy provided to participants in the therapy group of the study will include individual word retrieval treatment focused primarily on the phonological (sound) representation
- The word retrieval treatment will be delivered individually at 1 month post-stroke onset (following scanning) by qualified speech pathologists over 3 x 1 hour sessions a week for a period of 8 weeks.
- Stimuli (nouns) will be selected for treatment based on pre-test performance indicating difficulties with naming individual items. 2 sets of items will be selected (matched for relevant psycholinguistic variables), with one set treated and the other untreated to test for generalisation.
- The content of treatment is based on evidence for the effectiveness of word retrieval treatments that include repetition, phonological cueing, and phonological judgments (e.g., Nickels, 2000; Van Hees et al., 2013). In accordance with Leonard et al. (2008) and our work (Van Hees et al., 2013), patients are asked to attempt to name the item. They are then asked to produce the features of the item according to each cue word in a matrix. The cues include: first sound, syllables, last sound, association, and rhyme. If a participant is unable to produce a response, the clinician provides a response both orally and in written form. After all the features are produced, the participant is asked to name the item again. Another component of treatment will involve repetition of the name in the presence of its picture.
- Treatment will also include computer-based therapy (guided by the clinician, approximately 20% of each session), including picture naming for word retrieval, reading aloud for reading comprehension and script practice. Additional activities focused on phrase-level production may be included if impairments are identified (Rodriguez et al., 2013). Homework tasks may also be provided as part of the individualised treatment.
- Patients may receive usual care for other speech and communication impairments.
- Intervention adherence/fidelity will be assessed by recording a sample from a treatment session that will then be reviewed by one of the principal investigators. Strategies used to maintain/improve fidelity will include meetings with research therapists to discuss therapy provision.
Query!
Intervention code [1]
297248
0
Rehabilitation
Query!
Intervention code [2]
297249
0
Treatment: Other
Query!
Comparator / control treatment
Control group:
- 20 healthy age and gender matched controls will be scanned once to identify key regions normally activated in fMRI studies. This data will be critical for determining regions-of-interest and will determine whether normal or novel patterns of activity are observed in patients at each time-point.
- The control participants will also be screened using a brief (5-10 minute) cognitive assessment, the Montreal Cognitive Assessment (MoCA), to rule out cognitive impairment.
Usual Care treatment group:
- The usual care condition will comprise standard speech pathology intervention delivered at the frequency available in each specific health service in which the patient is recruited.
- Frequency and type of usual care intervention may be dependent on setting (e.g., acute hospital, inpatient rehabilitation, outpatient rehabilitation, community based) and will likely be influenced by clinician expertise, and by whether care is delivered in a private or a public health service setting. It may include individual sessions, computer-based therapy, and group sessions.
- Usual care therapy will be documented by the usual care therapists in the various health services, and participants (or their family members) will also keep a diary of therapy activities to assist with data checking by the research team.
- Usual care is unlikely to exceed on average 1-2 sessions of 45 minutes per week.
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
301239
0
Change in naming (Philadelphia Naming Test) at 3 months post stroke onset compared to baseline, as predicted by functional MRI of language-related brain activity at baseline (2-6 weeks post-stroke onset).
Query!
Assessment method [1]
301239
0
Query!
Timepoint [1]
301239
0
Baseline (2-6 weeks) to 3 months post stroke onset
Query!
Primary outcome [2]
301501
0
Change in comprehension (Comprehensive Aphasia Test) at 3 months post stroke onset compared to baseline, as predicted by functional MRI of language-related brain activity at baseline (2-6 weeks post-onset).
Query!
Assessment method [2]
301501
0
Query!
Timepoint [2]
301501
0
Baseline (2-6 weeks) to 3 months post stroke onset
Query!
Secondary outcome [1]
332192
0
Change in naming (Philadelphia Naming Test) at 6 months post stroke onset compared to baseline, as predicted by functional MRI of language-related brain activity at baseline (2-6 weeks post-stroke onset).
Query!
Assessment method [1]
332192
0
Query!
Timepoint [1]
332192
0
Baseline (2-6 weeks) to 6 months post stroke onset
Query!
Secondary outcome [2]
332710
0
Change in comprehension (Comprehensive Aphasia Test) at 6 months post stroke onset compared to baseline, as predicted by functional MRI of language-related brain activity at baseline (2-6 weeks post-stroke onset).
Query!
Assessment method [2]
332710
0
Query!
Timepoint [2]
332710
0
Baseline (2-6 weeks) to 6 months post stroke onset
Query!
Secondary outcome [3]
332711
0
Change in functional MRI measure of language-related brain activity at baseline (2-6 weeks post-stroke onset) to 3 and 6 months post-stroke onset
Query!
Assessment method [3]
332711
0
Query!
Timepoint [3]
332711
0
Baseline (2-6 weeks) to 6 months post stroke onset
Query!
Secondary outcome [4]
332712
0
Change in naming (Philadelphia Naming Test) at 3, 6 months post stroke onset compared to baseline.
Query!
Assessment method [4]
332712
0
Query!
Timepoint [4]
332712
0
Baseline (2-6 weeks) to 3 and 6 months post stroke onset
Query!
Secondary outcome [5]
332713
0
Change in comprehension (Comprehensive Aphasia Test) at 3, 6 months post stroke onset compared to baseline.
Query!
Assessment method [5]
332713
0
Query!
Timepoint [5]
332713
0
Baseline (2-6 weeks) to 3 and 6 months post stroke onset
Query!
Secondary outcome [6]
332714
0
Change in Western Aphasia Battery - Revised Aphasia Quotient at 3 months and 6 months post stroke onset compared to baseline
Query!
Assessment method [6]
332714
0
Query!
Timepoint [6]
332714
0
3 and 6 months post stroke onset
Query!
Secondary outcome [7]
332715
0
Change in Pyramids and Palm Trees Test at 3 and 6 months post-stroke onset
Query!
Assessment method [7]
332715
0
Query!
Timepoint [7]
332715
0
3 and 6 months post stroke onset
Query!
Secondary outcome [8]
333098
0
Changes in connected speech at 3 and 6 months post-stroke onset (based on picture description and the Nicholas and Brookshire procedure, and the Sentence Production Test).
Query!
Assessment method [8]
333098
0
Query!
Timepoint [8]
333098
0
3 and 6 months post stroke onset
Query!
Secondary outcome [9]
333099
0
Changes in sentence production at 3 and 6 months post-stroke onset (based on picture description and the Nicholas and Brookshire procedure
Query!
Assessment method [9]
333099
0
Query!
Timepoint [9]
333099
0
3 and 6 months post stroke onset
Query!
Secondary outcome [10]
333102
0
Change in naming (Philadelphia Naming Test) at 3 and 6 months post stroke onset compared to baseline, as predicted by lesion location (based on high resolution structural T1 MRI scan and voxel-based lesion symptom mapping) and white matter tract integrity (based on diffusion imaging measures of generalised fractional anisotropy including arcuate fasciculus).
Query!
Assessment method [10]
333102
0
Query!
Timepoint [10]
333102
0
3 and 6 months post stroke onset
Query!
Secondary outcome [11]
333103
0
Change in comprehension (Comprehensive Aphasia Test) at 3 and 6 months post stroke onset compared to baseline, as predicted by lesion location (based on high resolution structural T1 MRI scan and voxel-based lesion symptom mapping) and white matter tract integrity (based on diffusion imaging measures of generalised fractional anisotropy including arcuate fasciculus).
Query!
Assessment method [11]
333103
0
Query!
Timepoint [11]
333103
0
3 and 6 months post stroke onset
Query!
Secondary outcome [12]
333104
0
Change in naming (Philadelphia Naming Test) at 3 and 6 months post stroke onset compared to baseline as predicted by measures of cognition (RBANS verbal memory, Raven's progressive matrices, Test of Everyday Attention, Trail Making A & B).
Query!
Assessment method [12]
333104
0
Query!
Timepoint [12]
333104
0
3 and 6 months post stroke onset
Query!
Secondary outcome [13]
333105
0
Change in comprehension (Comprehensive Aphasia Test) at 3 and 6 months post stroke onset compared to baseline as predicted by measures of cognition (RBANS verbal memory, Raven's progressive matrices, Test of Everyday Attention, Trail Making A & B).
Query!
Assessment method [13]
333105
0
Query!
Timepoint [13]
333105
0
3 and 6 months post stroke onset
Query!
Secondary outcome [14]
352979
0
Changes in mood at 3, 6 months post stroke onset compared to baseline (Stroke and Aphasia Quality of Life Scale).
Query!
Assessment method [14]
352979
0
Query!
Timepoint [14]
352979
0
Baseline (2-4 weeks) to 6 months post-stroke onset.
Query!
Secondary outcome [15]
352980
0
Changes in language processing at 3, 6 months post stroke onset compared to baseline (based on Psycholinguistic Assessments of Language Processing in Aphasia subtests 5, 7, 8, 14, 15 and 27).
Query!
Assessment method [15]
352980
0
Query!
Timepoint [15]
352980
0
Baseline (2-4 weeks) to 6 months post-stroke onset.
Query!
Eligibility
Key inclusion criteria
People with aphasia:
- Single, first, left hemisphere stroke (as confirmed by CT/MRI) and speech and language impairment as identified by a speech pathologist or other relevant medical, nursing or allied health staff
-Below the aphasia cut-off (93.8 AQ) on the Western Aphasia Battery - Revised (WAB-R) or asphasia (including high level language deficits) as identified by a speech pathologist or other relevant medical, nursing or allied health staff
- MRI compatibility, and able to complete behavioural battery between 2 and 6 weeks post-stroke
- Have sufficient vision and hearing to complete the imaging and behavioural tasks
- Medically stable and able to attend and participate in a therapy program (8 weeks)
- English as a primary language prior to stroke
Control Group:
- healthy older adults matched for age and gender.
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
Yes
Query!
Key exclusion criteria
People with aphasia:
- Any other neurological disease or disorder, mental illness, head trauma, alcoholism, cerebral tumour or abscess.
- Any metals present in the body or other contraindications for MRI including claustrophobia.
- Current diagnosis of major clinical depression or other mental health condition that may affect participation.
- Severe dysarthria or apraxia of speech as determined by a speech pathologist.
- Severe auditory comprehension deficits as determined by the WAB-R which would preclude following directions for the scan.
- Substance abuse or dependence in the last 12 months.
Healthy controls:
- Any brain/neurological disorder, mental illness, head trauma, alcoholism and cerebral tumour
- Any contraindications for MRI – claustrophobia or metals in the body e.g., pacemaker, heart valve, dental bridge metal mesh implants/clips/wire sutures, hearing implant etc.
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Once meeting eligibility requirements for the study, participants will be randomised to either treatment group or usual care group by a computer code run by an independent, off-site researcher.
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Covariate adaptive random allocation will be employed, using the covariates of WAB-AQ severity level (mild 93.7-66; moderate: 65-33; severe: 32-0).
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
The people assessing the outcomes
The people analysing the results/data
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Efficacy
Query!
Statistical methods / analysis
A series of regression analyses will be run using the contrast estimates from the second level fMRI analysis in the aphasia group as independent variable predictors of the dependent variable of language recovery (naming, comprehension). Language performance dependent variables in this imaging analysis will be considered in terms of outcome (3 and 6 month performance) and percent of maximal achievable recovery . These same scores will be calculated for secondary outcome measures. Other factors of potential importance (e.g. age, lesion size) will be entered into the regression analyses. fMRI region of interest analyses will also be conducted based on healthy control performance and, based on our pilot data.
Query!
Recruitment
Recruitment status
Suspended
Query!
Date of first participant enrolment
Anticipated
6/04/2017
Query!
Actual
27/07/2017
Query!
Date of last participant enrolment
Anticipated
31/12/2021
Query!
Actual
24/02/2020
Query!
Date of last data collection
Anticipated
30/06/2022
Query!
Actual
Query!
Sample size
Target
115
Query!
Accrual to date
11
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
QLD
Query!
Recruitment hospital [1]
7661
0
Royal Brisbane & Womens Hospital - Herston
Query!
Recruitment hospital [2]
7662
0
Princess Alexandra Hospital - Woolloongabba
Query!
Recruitment hospital [3]
7663
0
The Prince Charles Hospital - Chermside
Query!
Recruitment hospital [4]
7664
0
Queen Elizabeth II Jubilee Hospital - Coopers Plains
Query!
Recruitment hospital [5]
7665
0
The Wesley Hospital - Auchenflower
Query!
Recruitment hospital [6]
7666
0
St Andrew's War Memorial Hospital - Brisbane
Query!
Recruitment hospital [7]
7667
0
Greenslopes Private Hospital - Greenslopes
Query!
Recruitment hospital [8]
7675
0
Redland Hospital - Cleveland
Query!
Recruitment hospital [9]
12190
0
Logan Hospital - Meadowbrook
Query!
Recruitment hospital [10]
12191
0
Redcliffe Hospital - Redcliffe
Query!
Recruitment postcode(s) [1]
15580
0
4029 - Herston
Query!
Recruitment postcode(s) [2]
15581
0
4102 - Woolloongabba
Query!
Recruitment postcode(s) [3]
15582
0
4032 - Chermside
Query!
Recruitment postcode(s) [4]
15583
0
4108 - Coopers Plains
Query!
Recruitment postcode(s) [5]
15584
0
4066 - Auchenflower
Query!
Recruitment postcode(s) [6]
15585
0
4000 - Brisbane
Query!
Recruitment postcode(s) [7]
15586
0
4120 - Greenslopes
Query!
Recruitment postcode(s) [8]
15593
0
4163 - Cleveland
Query!
Recruitment postcode(s) [9]
24361
0
4131 - Meadowbrook
Query!
Recruitment postcode(s) [10]
24362
0
4020 - Redcliffe
Query!
Recruitment postcode(s) [11]
24363
0
4114 - Logan City
Query!
Funding & Sponsors
Funding source category [1]
295691
0
Government body
Query!
Name [1]
295691
0
National Health and Medical Research Council (NHMRC)
Query!
Address [1]
295691
0
16 Marcus Clarke Street
Canberra City
ACT 2600
Query!
Country [1]
295691
0
Australia
Query!
Primary sponsor type
Individual
Query!
Name
Professor David Copland
Query!
Address
UQ Centre for Clinical Research
Faculty of Medicine
Level 3, Building 71/918, Herston
The University of Queensland 4029
Query!
Country
Australia
Query!
Secondary sponsor category [1]
294583
0
None
Query!
Name [1]
294583
0
Query!
Address [1]
294583
0
Query!
Country [1]
294583
0
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
297000
0
Royal Brisbane & Women's Hospital HREC
Query!
Ethics committee address [1]
297000
0
Royal Brisbane & Women's Hospital, Level 7 Block 7, Butterfield Street, Herston, Qld, 4029. Australia
Query!
Ethics committee country [1]
297000
0
Australia
Query!
Date submitted for ethics approval [1]
297000
0
22/07/2016
Query!
Approval date [1]
297000
0
15/09/2016
Query!
Ethics approval number [1]
297000
0
HREC/16/QRBW/376
Query!
Summary
Brief summary
Background: This NHMRC funded project (2016-2019) will address the fundamental lack of knowledge regarding the brain structure and function responsible for aphasia recovery and determine the best predictors of language improvement and treatment response in the sub-acute phase of brain recovery. Aims & Method: The specific aims of this research are to (1) Identify changes in brain activity from sub-acute to chronic phases in response to naming treatment versus usual care (2) Determine whether subacute brain activity predicts subsequent language recovery and successful treatment (3) Determine structural predictors of language recovery and treatment response (4) Develop a machine learning algorithm that accurately identifies individual patients who will recover language and make significant improvements. 90 participants with post-stroke aphasia will be scanned (at Herston Imaging Research Facility, RBWH campus) and tested on a battery of language tests at the sub-acute stage (1 month post-onset), then assigned to 8 weeks (3 times per week) naming and language treatment versus usual care and then scanned and retested at 3 and 6 months post-onset. 25 healthy older control participants will also be recruited and scanned. Outcomes: Using state-of-the art imaging techniques together with clinically meaningful markers of language function, this research will test for the first time whether brain structure and function in sub-acute stroke can reliably predict the recovery of specific language functions and treatment response.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
72670
0
Prof David Copland
Query!
Address
72670
0
UQ Centre for Clinical Research
Faculty of Medicine
Level 3, Building 71/918, Herston
The University of Queensland 4029
Query!
Country
72670
0
Australia
Query!
Phone
72670
0
+61 7 3346 5539
Query!
Fax
72670
0
Query!
Email
72670
0
[email protected]
Query!
Contact person for public queries
Name
72671
0
Tracy Roxbury
Query!
Address
72671
0
UQ Centre for Clinical Research
Faculty of Medicine
Level 3, Building 71/918, Herston
The University of Queensland 4029
Query!
Country
72671
0
Australia
Query!
Phone
72671
0
+61 7 3346 6110
Query!
Fax
72671
0
Query!
Email
72671
0
[email protected]
Query!
Contact person for scientific queries
Name
72672
0
David Copland
Query!
Address
72672
0
UQ Centre for Clinical Research
Faculty of Medicine
Level 3, Building 71/918, Herston
The University of Queensland 4029
Query!
Country
72672
0
Australia
Query!
Phone
72672
0
+61 7 3346 5539
Query!
Fax
72672
0
Query!
Email
72672
0
[email protected]
Query!
Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
Yes
Query!
What data in particular will be shared?
De-identified MRI scans and behavioural data
Query!
When will data be available (start and end dates)?
End 2020-2022
Query!
Available to whom?
Collaborators at NHMRC CRE n Aphasia (non-trial personnel; PI Copland is co-director) who have HREC approval to use the collected data for different projects.
Query!
Available for what types of analyses?
Analysis of predictors of aphasia recovery
Query!
How or where can data be obtained?
Data only available to staff associated with CRE subject to approval by Prof David Copland (PI -
[email protected]
)
Query!
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF